Lambkin-Williams R - Search Results

1

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN. Wilkinson TM, et al. Nat Med. 2012 Jan 29;18(2):274-80. doi: 10.1038/nm.2612. Nat Med. 2012. PMID: 22286307

2

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.

Pleguezuelos O, Robinson S, Fernández A, Stoloff GA, Mann A, Gilbert A, Balaratnam G, Wilkinson T, Lambkin-Williams R, Oxford J, Caparrós-Wanderley W. Pleguezuelos O, et al. Clin Vaccine Immunol. 2015 Jul;22(7):828-35. doi: 10.1128/CVI.00098-15. Epub 2015 May 20. Clin Vaccine Immunol. 2015. PMID: 25994549 Free PMC article. Clinical Trial.

3

Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study.

Killingley B, Enstone JE, Greatorex J, Gilbert AS, Lambkin-Williams R, Cauchemez S, Katz JM, Booy R, Hayward A, Oxford J, Bridges CB, Ferguson NM, Nguyen Van-Tam JS. Killingley B, et al. J Infect Dis. 2012 Jan 1;205(1):35-43. doi: 10.1093/infdis/jir701. Epub 2011 Nov 30. J Infect Dis. 2012. PMID: 22131338

4

Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model.

Huang KY, Li CK, Clutterbuck E, Chui C, Wilkinson T, Gilbert A, Oxford J, Lambkin-Williams R, Lin TY, McMichael AJ, Xu XN. Huang KY, et al. J Infect Dis. 2014 May 1;209(9):1354-61. doi: 10.1093/infdis/jit650. Epub 2014 Jan 10. J Infect Dis. 2014. PMID: 24415790

5

Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.

Rennie P, Bowtell P, Hull D, Charbonneau D, Lambkin-Williams R, Oxford J. Rennie P, et al. Respir Res. 2007 May 17;8(1):38. doi: 10.1186/1465-9921-8-38. Respir Res. 2007. PMID: 17509128 Free PMC article.

6

The threat of avian influenza H5N1: 'do we have the tools for the job'?

Oxford J, Lambkin-Williams R, Mann A. Oxford J, et al. Antivir Chem Chemother. 2007;18(2):71-4. doi: 10.1177/095632020701800202. Antivir Chem Chemother. 2007. PMID: 17542151 Free article.

7

Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals.

Bagga B, Woods CW, Veldman TH, Gilbert A, Mann A, Balaratnam G, Lambkin-Williams R, Oxford JS, McClain MT, Wilkinson T, Nicholson BP, Ginsburg GS, Devincenzo JP. Bagga B, et al. Antivir Ther. 2013;18(6):785-91. doi: 10.3851/IMP2629. Epub 2013 May 28. Antivir Ther. 2013. PMID: 23714753

8

Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination.

Moss AJ, Gaughran FP, Karasu A, Gilbert AS, Mann AJ, Gelder CM, Oxford JS, Stephens HA, Lambkin-Williams R. Moss AJ, et al. PLoS One. 2013 Aug 9;8(8):e71376. doi: 10.1371/journal.pone.0071376. eCollection 2013. PLoS One. 2013. PMID: 23951151 Free PMC article. Clinical Trial.

9

An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.

Lambkin-Williams R, Gelder C, Broughton R, Mallett CP, Gilbert AS, Mann A, He D, Oxford JS, Burt D. Lambkin-Williams R, et al. PLoS One. 2016 Dec 22;11(12):e0163089. doi: 10.1371/journal.pone.0163089. eCollection 2016. PLoS One. 2016. PMID: 28005959 Free PMC article. Clinical Trial.

10

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial.

Jones S, Evans K, McElwaine-Johnn H, Sharpe M, Oxford J, Lambkin-Williams R, Mant T, Nolan A, Zambon M, Ellis J, Beadle J, Loudon PT. Jones S, et al. Vaccine. 2009 Apr 21;27(18):2506-12. doi: 10.1016/j.vaccine.2009.02.061. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19368793 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page